Amantadine for adynamic speech: Possible benefit for aphasia?

American Journal of Physical Medicine and Rehabilitation

Volumn 86, Issue 8, 2007, Pages 605-612

  Barrett, Anna M ^a,c   Eslinger, Paul J ^b  

^a KESSLER FOUNDATION   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c Stroke/KMRREC   (United States)

Author keywords

Amantadine; Aphasia; Rehabilitation

Indexed keywords

AMANTADINE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANALYTIC METHOD; APHASIA; ARTICLE; ATAXIC APHASIA; CANCER SURGERY; CASE REPORT; CONTROLLED STUDY; DRUG DOSE INCREASE; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; PILOT STUDY; PSYCHOMETRY; REHABILITATION CARE; SCORING SYSTEM; SPEECH DISORDER; STROKE; VERBAL BEHAVIOR;

ADULT; AGED; AMANTADINE; APHASIA, BROCA; BRAIN NEOPLASMS; CEREBROVASCULAR ACCIDENT; CONTROLLED CLINICAL TRIALS; DOPAMINE AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RETROSPECTIVE STUDIES;

EID: 34547690918     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e31811473b3     Document Type: Article

References (35)

1. Herrmann M, Wallesch CW: Psychosocial changes and psychosocial adjustment with chronic and severe non-fluent aphasia. Aphasiology 1989;3:513-26
2. Greener J, Enderby P, Whurr R: Pharmacological treatment for aphasia following stroke. Cochrane Database Syst Rev 2001;(4):CD000424
3. DeMarchi R, Bansal V, Hung A, et al: Review of awakening agents. Can J Neurol Sci 2005;32:4-17
4. Raymer AM: Treatment of adynamia in aphasia. Front Biosci 2003;8:s845-51
5. Taus C, Giuliani G, Pucci E, D'Amico R, Solari A: Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2003;(2):CD002818
6. Drayton SJ, Davies K, Steinberg M, Leroi I, Rosenblatt A, Lyketsos CG: Amantadine for executive dysfunction syndrome in patients with dementia. Psychosomatics 2004;45:205-9
7. Rothberg MB, Bellantonio S, Rose DN: Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Ann Intern Med 2003;139:321-9
8. Krupp LB, Coyle PK, Doscher C, et al: Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo. Neurology 1995;45:1956-61
9. Amantadine and other antiglutamate agents: management of Parkinson's disease. Mov Disord 2002;17(suppl 4):S13-22
10. Meythaler JM, Brunner RC, Johnson A, Novack TA: Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil 2002;17:300-13
11. Whyte J, Vaccaro M, Grieb-Neff P, Hart T: Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. J Head Trauma Rehabil 2002;17:284-99
12. 11a. Zafonte RD, Watanabe T, Mann NR: Amantadine: a potential treatment for the minimally conscious state. Brain Inj 1998;12:617-21
13. Sarno JE, Gainotti G: The psychological and social sequelae of aphasia, in Acquired Aphasia, ed 3. New York, Academic Press, 1998, pp 569-94
14. Aphasia. National Institute on Deafness and Other Communication Disorders Web site. Available at: http://www.nidcd.nih.gov/health/voice/aphasia.asp. Accessed June 2, 2005.
15. Imamura T, Suzuki K, Yamadori A, et al: Improved perseveration with amantadine. [in Japanese]. No To Shinkei 1994;46:556-62
16. Pfeiffer RF: Amantadine-induced "vocal" myoclonus. Mov Disord 1996;11:104-6
17. Schneider WN, Drew-Cates J, Wong TM, Dombovy ML: Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study. Brain Inj 1999;13:863-72
18. Arciniegas DB, Frey KL, Anderson CA, Brousseau KM, Harris SN: Amantadine for neurobehavioural deficits following delayed post-hypoxic encephalopathy. Brain Inj 2004;18:1309-18
19. Gold M, VanDam D, Silliman ER: An open-label trial of bromocriptine in nonfluent aphasia: a qualitative analysis of word storage and retrieval. Brain Lang 2000;74:141-56
20. Sabe L, Leiguarda R, Starkstein SE: An open-label trial of bromocriptine in nonfluent aphasia. Neurology 1992;42:1637-8
21. Albert ML, Goodglass H, Helm NA, Rubens AB, Alexander MP: Clinical Aspects of Dysphasia. New York, Springer-Verlag, 1981
22. Doty L, Bowers D, Heilman KM: Florida mental status exam for progressive dementia screening. Gerontologist 1990;30:20
23. Benton AL, Hamsher K: Multilingual Aphasia Examination. Iowa City, IA, AJA Associates, 1989
24. Amantadine, in: MD Consult drug information, Elsevier. Available at: www.mdconsult.com. Accessed on June 15, 2007
25. Silver DE, Sahs AL: Livedo reticularis in Parkinson's disease patients treated with amantadine hydrochloride. Neurology 1972;22:665-9
26. Benson DF, Ardilla A: Extrasylvian (transcortical) aphasia syndromes, in: Aphasia: A Clinical Perspective. New York, Oxford University Press, 1996, pp 152-5
27. Mazzoni M, Vista M, Pardossi L, Avila L, Bianchi F, Moretti P: Spontaneous evolution of aphasia after ischaemic stroke. Aphasiology 1992;6:387-96
28. Mazzoni M, Vista M, Geri E, Avila L, Bianchi F, Moretti P: Comparison of language recovery in rehabilitated and matched, nonrehabilitated aphasic patients. Aphasiology 1995;9:553-63
29. Patrick PD, Buck ML, Conaway MR, Blackman JA: The use of dopamine enhancing medications with children in low response states following brain injury. Brain Inj 2003;17:497-506
30. Nickels JL, Schneider WN, Dombovy ML, Wong TM: Clinical use of amantadine in brain injury rehabilitation. Brain Inj 1994;8:709-18
31. Kraus MF, Maki P: The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury. Brain Inj 1997;11:455-60
32. Klein RB, Albert ML: Can drug therapies improve language functions of individuals with aphasia? A review of the evidence. Semin Speech Lang 2004;25:193-204
33. Postma JU, Van Tilburg W: Visual hallucinations and delirium during treatment with amantadine (Symmetrel). J Am Geriatr Soc 1975;23:212-5
34. Millet VM, Dreisbach M, Bryson YJ: Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine. Antimicrob Agents Chemother 1982;21:1-4
35. Brott T, Adams HP Jr, Olinger CP, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-70